Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.
Alberts SR; Erlichman C; Sloan J; Okuno SH; Burch PA; Rubin J; Pitot HC; Goldberg RM; Adjei AA; Atherton PJ; Kaufmann SH; Annals Of Oncology: Official Journal Of The European Society For Medical Oncology / ESMO, 2001, vol. 12, issue 5, p 627, ISSN 09237534. ISBN 09237534.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef